Tech Center 1600 • Art Units: 1637 1681 1699
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17933833 | NANOPORE SEQUENCING | Non-Final OA | Illumina, Inc. |
| 18325759 | COMPOSITIONS AND METHODS FOR ENRICHING METHYLATED POLYNUCLEOTIDES | Non-Final OA | GUARDANT HEALTH, INC. |
| 17285362 | METHOD FOR MEASURING THE INFECTIVITY OF REPLICATION DEFECTIVE VIRAL VECTORS AND VIRUSES | Non-Final OA | REGENXBIO Inc. |
| 18038454 | GRAPHENE-BASED BIOSENSOR AND DETECTION METHOD USING SAME | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17466309 | DISTINGUISHING RARE VARIATIONS IN A NUCLEIC ACID SEQUENCE FROM A SAMPLE | Final Rejection | Bio-Rad Laboratories, Inc. |
| 17619154 | METHOD FOR DIAGNOSIS OF EARLY AGEING OF THE SKIN | Final Rejection | L'OREAL |
| 17373653 | cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS | Final Rejection | Becton, Dickinson and Company |
| 17637642 | KIT FOR EVALUATING A GENE MUTATION RELATED TO MYELOPROLIFERATIVE NEOPLASMS | Non-Final OA | TOYO KOHAN CO., LTD. |
| 17615271 | A METHOD FOR DETERMINING A YEAST HAVING EXTRACELLULAR GLUCOAMYLASE STA1p ACTIVITY IN A SAMPLE AND TOOLS AND USES RELATED THERETO | Non-Final OA | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY |
| 18318402 | COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE MONITORING | Non-Final OA | Life Technologies Corporation |
| 17118429 | NUCLEIC ACID AMPLIFICATION METHOD | Non-Final OA | Keygene N.V. |
| 17240865 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | Final Rejection | Cepheid |
| 18006200 | METHODS OF IDENTIFYING AUTISM SPECTRUM DISORDER | Non-Final OA | WASHINGTON STATE UNIVERSITY |
| 18145735 | COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS | Non-Final OA | Meso Scale Technologies, LLC. |
| 17260611 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | Non-Final OA | Oxford Nanopore Technologies PLC |
| 18067247 | AORTA-SPECIFIC DNA METHYLATION PATTERNS IN CELL-FREE DNA FROM PATIENTS WITH BICUSPID AORTIC VALVE-ASSOCIATED AORTOPATHY | Non-Final OA | UTI Limited Partnership |
| 18536108 | CANCER DETECTION METHOD, KIT, AND SYSTEM | Non-Final OA | MIRONCOL DIAGNOSTICS, INC. |
| 18528750 | USING DEEP RNA SEQUENCING DATA TO IDENTIFY ANTIMICROBIAL-RESISTANT BACTERIA | Non-Final OA | Rhode Island Hospital |
| 18555657 | METHODS AND COMPOSITIONS FOR REDUCING AUTOFLUORESCENCE | Non-Final OA | Advanced Cell Diagnostics, Inc. |
| 18477825 | SYSTEMS AND COMPOSITIONS FOR DETECTING A BIOLOGICAL SAMPLE AND METHODS THEREOF | Non-Final OA | QCDx LLC |
| 18546431 | DNA FRAGMENT JOINING DETECTING METHOD AND KIT THEREOF | Non-Final OA | ACT GENOMICS (IP) LIMITED |
| 18274453 | SYNTHETIC POLYNUCLEOTIDES AND METHODS FOR SELECTIVELY AMPLIFYING ALLELES | Non-Final OA | RHODX, Inc. |
| 18259433 | LACTIC ACID BACTERIUM DETECTION PRIMER SET, AND DETECTION METHOD USING SAID PRIMER SET | Non-Final OA | NIHON BERUMU CO., LTD. |
| 18000615 | MULTI-SENSING OF NUCLEIC ACID AND SMALL MOLECULE MARKERS | Non-Final OA | LogicInk Corporation |
| 18316080 | TARGET-ENRICHED MULTIPLEXED PARALLEL ANALYSIS FOR ASSESSMENT OF FETAL DNA SAMPLES | Non-Final OA | NIPD GENETICS PUBLIC COMPANY LIMITED |
| 18252489 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | Non-Final OA | MULTIPLEXDX, S.R.O. |
| 17850599 | DIAGNOSIS OF FETAL ABNORMALITIES USING POLYMORPHISMS INCLUDING SHORT TANDEM REPEATS | Final Rejection | GPB Scientific, LLC |
| 18158396 | GENE EXPRESSION PROFILES TO PREDICT BREAST CANCER OUTCOMES | Final Rejection | British Columbia Cancer Agency Branch |
| 17923562 | MULTIPLEX DETECTION OF NUCLEIC ACIDS USING MIXED REPORTERS | Final Rejection | SpeeDx Pty Ltd |
| 17589879 | METHOD FOR PRODUCING RNA | Non-Final OA | CureVac Real Estate GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy